Skip to main content

Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis in children: a case-control study

Abstract

Background

This study was performed to summarize the clinical and laboratory features of children with Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis.

Methods

A case-control study of children diagnosed with Kikuchi-Fujimoto disease at Beijing Children’s Hospital from January 2015 to December 2023 was conducted to determine the characteristics of the disease when concurrent with aseptic meningitis or encephalitis.

Results

Our cohort of 64 cases of Kikuchi-Fujimoto disease included 16 children with central nervous system involvement and 48 controls. Among the 16 affected children, the male: female ratio was 1.7:1.0. The age at onset ranged from 3 to 13 years, with a median age of 8 years. All 16 cases had fever, 15 had cervical lymph node tenderness, 11 had headache, and 14 showed decreased white blood cell counts in routine blood tests. Imaging of the head revealed abnormalities in 11 cases, specifically leukoencephalopathy with mostly bilateral involvement. Cervical lymph node tenderness, headache, confusion, convulsions, and elevated C-reactive protein were significantly associated with Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis (p < 0.05). There was also a significant difference in lactate dehydrogenase levels between children with and without central nervous system involvement (575.8 ± 221.3 vs. 440.0 ± 163.1 U/L, p = 0.014).

Conclusions

For children with Kikuchi-Fujimoto disease, careful evaluation for central nervous system involvement is warranted when cervical lymph node tenderness, elevated C-reactive protein, or elevated lactate dehydrogenase is present. In children presenting with aseptic meningitis or encephalitis, Kikuchi-Fujimoto disease should be considered as a differential diagnosis.

Clinical trial number

Not applicable.

Peer Review reports

Background

Kikuchi-Fujimoto disease (KFD), also known as histiocytic necrotizing lymphadenitis, is a self-limiting condition [1]. The cause of KFD remains unknown [2]. While earlier reports have suggested KFD predominantly affects female patients, more recent studies have shown similar or even lower rates in women than in men [3]. Common clinical signs and symptoms include lymphadenopathy, fever, rash, joint pain, weakness, and enlargement of the liver and spleen. KFD can lead to various complications, such as systemic lupus erythematosus and arthritis [4]. It may also involve the central nervous system (CNS), presenting as aseptic meningitis, encephalitis, and related conditions [5]. The clinical manifestations of KFD are diverse, and individual signs and symptoms are nonspecific. Cases involving the CNS are rarely reported, which can lead to misdiagnosis, missed diagnosis, or delayed diagnosis. Therefore, the aim of this paper is to retrospectively summarize the clinical characteristics of children admitted to Beijing Children’s Hospital with KFD involving the CNS and thus provide a reference for early clinical recognition and accurate diagnosis.

Materials and methods

We conducted a case-control study of children admitted to Beijing Children’s Hospital, China, from 1 January 2015 to 31 December 2023. Cases were defined as children who had KFD concurrent with aseptic meningitis or encephalitis. The inclusion criteria were an age of 29 days to 18 years, a histopathological diagnosis consistent with histiocytic necrotizing lymphadenitis based on cervical lymph node biopsy, the presence of neurological symptoms or signs, and cerebrospinal fluid (CSF) abnormalities or abnormal findings on cranial magnetic resonance imaging (MRI). Additionally, three controls were randomly selected for each case, matched by sex, age, and admission date (within 7 days of the case’s admission date). Controls were defined as children who had KFD without aseptic meningitis or encephalitis.

The children’s clinical information was obtained from the hospital’s medical record system. General data (sex, age, and time of onset) and clinical characteristics (clinical manifestations, laboratory results, etiological findings, and medication use) were collected. Descriptive statistics were presented as mean or median for continuous variables and as frequency (percentage) for categorical variables. Continuous variables between two groups were compared using the Mann–Whitney test for nonparametric data or the independent t-test for parametric data, as appropriate. Factors associated with KFD concurrent with aseptic meningitis or encephalitis were identified through univariate analysis. A p-value of < 0.05 was considered statistically significant. Statistical analyses were performed using SPSS 25.0 software (IBM Corp., Armonk, NY, USA).

Results

Of the 16 patients who met the case criteria for our study, we identified matched controls, resulting in a total of 64 study participants (16 cases and 48 controls). All 16 cases of KFD concurrent with aseptic meningitis or encephalitis were diagnosed with histiocytic necrotizing lymphadenitis by cervical lymph node biopsy. Among them, there were 10 male and 6 female, yielding a male: female ratio of 1.7:1.0. The age at onset ranged from 3 to 13 years, with a median age of 8 years. All 16 cases presented with fever; 15 had cervical lymph node tenderness, 6 had a rash, and 1 had joint pain. Regarding CNS involvement, 10 cases were diagnosed with aseptic encephalitis and 6 with aseptic meningitis. Headache occurred in 11 cases, confusion in 6, and convulsions in 5. One patient exhibited neck stiffness. The interval between lymph node enlargement and onset of CNS symptoms ranged from 2 days to 8 weeks. The duration of CNS clinical manifestations lasted from 1 to 11 weeks (Table 1). In laboratory tests, 14 of the 16 children had decreased white blood cell counts. Nine cases had an elevated C-reactive protein (CRP) concentration, and 14 cases had an increased erythrocyte sedimentation rate (ESR). Ten cases had elevated CSF cell counts, primarily monocytes. CSF glucose was decreased in 4 cases, protein was increased in 10, and intracranial pressure was elevated in 4. CSF pathogen testing—including Epstein–Barr virus, cytomegalovirus, herpes simplex virus, enterovirus, and other pathogenic nucleic acid tests—was negative. Cranial MRI results were available for all 16 patients; 11 showed abnormalities, specifically leukoencephalopathy with mostly bilateral involvement, scattered lesions, and predominant involvement of the frontoparietal white matter (Table 2). Of the 16 patients, 11 received glucocorticoid therapy and 10 received intravenous immunoglobulin therapy. Recurrence occurred in two cases, and no recurrence or sequelae were observed in the remaining cases.

Table 1 Clinical features of 16 children with KFD concurrent with aseptic meningitis or encephalitis
Table 2 Laboratory test results and imaging findings of children with KFD concurrent with aseptic meningitis or encephalitis

In total, 48 cases of KFD without aseptic meningitis or encephalitis were diagnosed with histiocytic necrotizing lymphadenitis by cervical lymph node biopsy. Among them, there were 33 male and 15 female children, yielding a male: female ratio of 2.2:1.0. The age at onset ranged from 5 to 13 years, with a median age of 10 years. All 48 cases presented with fever; 30 had cervical lymph node tenderness, 6 had a rash, and none reported joint pain. In laboratory tests, 23 cases showed decreased white blood cell counts. Eight cases had an elevated CRP concentration, and 30 cases had an increased ESR. Seven patients received glucocorticoid therapy, and two were treated with intravenous immunoglobulin. Recurrence occurred in eight cases; no recurrence or sequelae were observed in the remaining cases. Table 3 presents risk factors for KFD concurrent with aseptic meningitis or encephalitis as identified by univariate analysis. Cervical lymph node tenderness, headache, confusion, convulsions, and elevated CRP were significantly associated with CNS involvement (p < 0.05). Additionally, there was a significant difference in lactate dehydrogenase (LDH) levels between patients with and without CNS involvement (575.8 ± 221.3 vs. 440.0 ± 163.1 U/L, p = 0.014).

Table 3 Patients with KFD with and without aseptic meningitis or encephalitis

Discussion

KFD is a benign disease of unknown etiology, most commonly seen in Asian countries and rarely reported in Western countries [6]. Its clinical manifestations are varied and lack specific symptoms or signs. CNS involvement in KFD is rare and often misdiagnosed as other neurological disorders [7]. Neurological complications such as aseptic meningitis, cerebellar ataxia, and mononeuritis multiplex occur in approximately 5% of cases [8]. In this study, children with KFD concurrent with aseptic meningitis or encephalitis ranged in age from 3 to 13 years and were predominantly male. The main clinical features included fever, cervical lymph node swelling and tenderness, and leukopenia. Headache was the most prominent symptom in cases with CNS involvement. Cervical lymph node tenderness, headache, confusion, convulsions, and elevated CRP were significantly associated with KFD concurrent with aseptic meningitis or encephalitis, and LDH levels were also significantly higher in these patients than in those without CNS involvement. Clinicians should carefully assess for neurological symptoms and promptly perform CSF analysis and cranial imaging to facilitate early diagnosis and prevent delays in treatment.

Consistent with previous research [9], CSF examination in cases of KFD concurrent with aseptic meningitis or encephalitis was largely sterile. In this study, 62.5% of cases showed increased CSF cell counts, predominantly mononuclear cells, and all CSF etiology tests were negative. Aseptic meningitis is the most commonly reported neurologic complication of KFD [10]. Head imaging changes were observed in 68.8% of cases, primarily presenting as leukoencephalopathy with mostly bilateral involvement. One report described brain MRI findings of extensive T2-weighted hyperintensity, focal diffusion restriction, and microhemorrhages within the deep gray nuclei and surrounding white matter [11]. Previous studies have also noted CNS involvement manifesting as multiple peripheral neuropathy, hemiparesis, and brachial plexus injury [12, 13], although such findings were not observed in the cases from this study, warranting further attention.

KFD concurrent with aseptic meningitis or encephalitis typically occurs 2 to 3 weeks after the onset of lymphadenopathy, while meningitis as the initial symptom of KFD is rare. The course of KFD with CNS involvement usually lasts 2 to 3 weeks, although durations of 2 to 4 months have also been reported [14]. In this study, the interval between lymph node enlargement and the appearance of CNS symptoms ranged from as little as 2 days to as long as 8 weeks. The duration of CNS clinical manifestations ranged from 1 to 11 weeks.

KFD is thought to be mediated by an aberrant type I interferon response, likely driven by plasmacytoid dendritic cells and T cells [15]. Evidence of C1s deficiency in a patient with KFD further supports the role of complement abnormalities in the disease’s pathogenesis [16]. Additionally, one study suggests that the encephalitis complication of KFD may be autoimmune in nature and mediated by cytotoxic T cells [17].

Because of the rarity of the disease, there are no established consensus guidelines for its treatment. Mild cases are generally believed to respond well to antipyretics and nonsteroidal anti-inflammatory drugs alone, while corticosteroids are considered necessary for extranodal manifestations such as aseptic meningitis [9]. One study reported that among 41 cases of KFD with aseptic meningitis, 24 patients received steroid therapy, with 79% achieving full recovery [14]. As shown in Table 3, among the 16 patients with KFD and CNS involvement in this study, 11 received steroid therapy, and the prognosis was favorable in most cases, with the exception of 2 instances of recurrence.

This study had two main limitations: it was retrospective in nature, and no further analysis of pathogenesis was performed.

Conclusions

For children with KFD, clinicians should be alert to the possibility of CNS involvement when lymph node tenderness, elevated CRP, or elevated LDH is present. In cases of aseptic meningitis or encephalitis in children, KFD involving the CNS should be considered as a differential diagnosis.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

CNS:

Central nervous system

CRP:

C-reactive protein

ESR:

Erythrocyte sedimentation rate

CSF:

Cerebrospinal fluid

KFD:

Kikuchi-Fujimoto disease

LDH:

Lactate dehydrogenase

MRI:

Magnetic resonance imaging

References

  1. Anamarija M, Perry SM, Choi. Kikuchi-Fujimoto disease: A review [J]. Arch Pathol Lab Med. 2018;142(11):1341–6.

    Article  Google Scholar 

  2. Chen C, Lin S-H, Medeiros LJ. Kung-Chao Chang. Kikuchi disease: an unusual case with features suggesting an infectious aetiology [J]. Patholog. 2018;50(6):694–7.

    Google Scholar 

  3. Shoba N, Selvanathan S, Suhumaran VK, Sahu CY, Chong. Natalie Woon Hui Tan, Koh Cheng thoon. Kikuchi-Fujimoto disease in children[J]. J Paediatr Child Health. 2020;56(3):389–93.

    Google Scholar 

  4. Guillaume Dumas V, Prendki J, Haroche Z, Amoura P, Cacoub L, Galicier, et al. Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature [J]. Medicine. 2014;93(24):372–82.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tomoko Komagamine T, Nagashima M, Kojima N, Kokubun T, Nakamura K, Hashimoto, et al. Recurrent aseptic meningitis in association with Kikuchi-Fujimoto disease: case report and literature review[J]. BMC Neurol. 2012;12:112.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Laju M, Mathew R, Kapila RA, Schwartz. Kikuchi-Fujimoto disease: a diagnostic dilemma [J]. Int J Dermatol. 2016;55(10):1069–75.

    Article  Google Scholar 

  7. Hidenori Kido O, Kano A, Hamai H, Masuda Y, Fuchinoue M, Nemoto, et al. Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: a case report[J]. BMC Neurol. 2017;17(1):22.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Masooma Hashmat S, Iftikhar MAU, Rehman AU, Rehman H, Farooq A, Asmar, et al. Aseptic meningitis in Kikuchi-Fujimoto Disease - Rare manifestation of a rare disease [J]. eNeurologicalSci. 2022;29:100429.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Shiori Sekiguchi Y, Yamamoto S, Hatakeyama. Masami Matsumura. Recurrent Aseptic Meningitis Associated with Kikuchi’s Disease (Histiocytic Necrotizing Lymphadenitis): A Case Report and Literature Review.[J]. Internal medicine. 2021;60(11):1779–1784.

  10. Mohamed Shabana and Worthy Warnack Neurology. An atypical neurologic complication of Kikuchi-Fujimoto Disease[J]. Neurology(R) Neuroimmunol Neuroinflammation. 2020;7:e707.

    Article  Google Scholar 

  11. Murva Asad, Arpan R, Mehta. Dermot Mallon. A rare neurological presentation of Kikuchi-Fujimoto Disease[J]. JAMA Neurol. 2024;81(7):773–4.

    Article  Google Scholar 

  12. Hidenori Kido O, Kano A, Hamai H, Masuda Y, Fuchinoue M, Nemoto, et al. Kikuchi-Fujimoto disease complicated by peripheral Neuropathy[J]. BMC Neurol. 2017;17(1):22.

    PubMed  PubMed Central  Google Scholar 

  13. Luís F, Gonçalves LV, Debelenko KJ, Bhambhani A, Scheid, Deniz Altinok. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) with CNS involvement in a child[J]. Pediatr Radiol. 2014;44(2):234–8.

    Article  Google Scholar 

  14. Yanna Song S, Liu L, Song H, Chen M, Bai J. Case report: Histiocytic necrotizing lymphadenitis (Kikuchi–Fujimoto Disease) concurrent with aseptic Meningitis[J]. Front Neurol. 2021;12:565387.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Elizabeth Y, Li J, Xu ND, Nelson DT, Teachey K, Tan N, Romberg, et al. Kikuchi-Fujimoto disease is mediated by an aberrant type I interferon response[J]. Mod Pathology: Official J United States Can Acad Pathol Inc. 2022;35(4):462–9.

    Article  Google Scholar 

  16. Jalila Alshekaili I, Nasr M, Al-Rawahi Z, Ansari NA, Rahbi HA, Balushi. Shoaib al-Zadjali, Mahmood al kindi, almundher al-Maawali, Matthew C cook. A homozygous loss-of-function C1S mutation is associated with Kikuchi-Fujimoto disease[J]. Clinical immunology (Orlando, Fla.). 2023;252:109646.

  17. Chen S, Liang X-L, He S, Zhang J-W, Li S-J. Encephalitis in Kikuchi–Fujimoto disease being immune–mediated[J]. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2022;43(6):3983–7.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Angela Morben, DVM, ELS, from Liwen Bianji (Edanz) (www.liwenbianji.cn) for editing the English text of a draft of this manuscript.

Funding

This work was supported by Capital’s Funds for Health Improvement and Research (2024-1-2092) and the 2022 Beijing Major Epidemic Prevention and Control Specialty Construction Project (2-1-2-6-15).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by BL and YS. The first draft of the manuscript was written by BL and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Gang Liu.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Beijing Children’s Hospital, Capital Medical University (2023-E-119-R). The requirement for informed consent to participate was waived by the Ethics Committee of Beijing Children’s Hospital Affiliated to Capital Medical University because of the retrospective nature of the study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, B., Sun, Y., Hu, B. et al. Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis in children: a case-control study. BMC Pediatr 25, 287 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12887-025-05648-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12887-025-05648-y

Keywords